These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12015787)

  • 1. The effect of enzyme inhibitor and absorption site following [D-ala2, D-leu5]enkephalin oral administration in rats.
    Lee HJ; Amidon GL
    Biopharm Drug Dispos; 2002 May; 23(4):131-41. PubMed ID: 12015787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acids in the rat intestinal lumen regulate their own absorption from a distant intestinal site.
    Mourad FH; Barada KA; Khoury C; Hamdi T; Saadé NE; Nassar CF
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G292-8. PubMed ID: 19541927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal metabolism and absorption of cholecystokinin analogs in rats.
    Su SF; Amidon GL; Lee HJ
    Biochem Biophys Res Commun; 2002 Apr; 292(3):632-8. PubMed ID: 11922613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the plasma pharmacokinetics, tissue distribution, excretion and effects on cholesterol pharmacokinetics of a novel hydrophilic compound, FM-VP4, following administration to rats.
    Wasan KM; Peteherych KD; Najafi S; Zamfir C; Pritchard PH
    J Pharm Pharm Sci; 2001; 4(3):207-16. PubMed ID: 11737986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of a novel histone deacetylase inhibitor, apicidin, in rats.
    Shin BS; Chang HS; Park EH; Yoon CH; Kim HY; Kim J; Ryu JK; Zee OP; Lee KC; Cao D; Yoo SD
    Biopharm Drug Dispos; 2006 Mar; 27(2):69-75. PubMed ID: 16299816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.
    Khalili P; Naimi E; Sun WY; Knaus EE; Wiebe LI
    Biopharm Drug Dispos; 2003 Dec; 24(9):385-95. PubMed ID: 14689467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-linear pharmacokinetics of oleanolic acid after intravenous and oral administration in rats.
    Jeong DW; Kim YH; Kim HH; Ji HY; Yoo SD; Choi WR; Lee SM; Han CK; Lee HS
    Biopharm Drug Dispos; 2007 Mar; 28(2):51-7. PubMed ID: 17163409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro stability and in vivo pharmacokinetic studies of a model opioid peptide, H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs.
    Yang JZ; Chen W; Borchardt RT
    J Pharmacol Exp Ther; 2002 Nov; 303(2):840-8. PubMed ID: 12388671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of IDN-6556 (3-[2-(2-tert-butyl-phenylaminooxalyl)-amino]-propionylamino]-4-oxo-5-(2,3,5,6-tetrafluoro-phenoxy)-pentanoic acid): a liver-targeted caspase inhibitor.
    Hoglen NC; Chen LS; Fisher CD; Hirakawa BP; Groessl T; Contreras PC
    J Pharmacol Exp Ther; 2004 May; 309(2):634-40. PubMed ID: 14742742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-independent pharmacokinetics of clindamycin after intravenous and oral administration to rats: contribution of gastric first-pass effect to low bioavailability.
    Yang SH; Lee MG
    Int J Pharm; 2007 Mar; 332(1-2):17-23. PubMed ID: 17157458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of inhibiting cytochrome P450 3A, p-glycoprotein, and gastric acid secretion on the oral bioavailability of methadone in dogs.
    Kukanich B; Lascelles BD; Aman AM; Mealey KL; Papich MG
    J Vet Pharmacol Ther; 2005 Oct; 28(5):461-6. PubMed ID: 16207309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.
    Ramanathan-Girish S; Catz P; Creek MR; Wu B; Thomas D; Krogstad DJ; De D; Mirsalis JC; Green CE
    Int J Toxicol; 2004; 23(3):179-89. PubMed ID: 15204721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of difloxacin in pigs and broilers following intravenous, intramuscular, and oral single-dose applications.
    Ding HZ; Yang GX; Huang XH; Chen ZL; Zeng ZL
    J Vet Pharmacol Ther; 2008 Jun; 31(3):200-4. PubMed ID: 18471140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability, blood partition, and pharmacokinetics of a new reversible proton pump inhibitor, YJA-20379-1.
    Kim SH; Han KS; Choi WS; Chang MS; Lee MG
    Res Commun Mol Pathol Pharmacol; 1997 Oct; 98(1):77-84. PubMed ID: 9434317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral bioavailability and intestinal secretion of amitriptyline: Role of P-glycoprotein?
    Abaut AY; Chevanne F; Le Corre P
    Int J Pharm; 2007 Feb; 330(1-2):121-8. PubMed ID: 17092666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
    Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
    Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption and elimination of D and C Red No. 28 in male F-344 rats.
    Sweet CJ; Sólyom AM; Sipes IG
    Food Chem Toxicol; 2004 Apr; 42(4):641-8. PubMed ID: 15019189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rodent pharmacokinetics and receptor occupancy of the GABAA receptor subtype selective benzodiazepine site ligand L-838417.
    Scott-Stevens P; Atack JR; Sohal B; Worboys P
    Biopharm Drug Dispos; 2005 Jan; 26(1):13-20. PubMed ID: 15578749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.